Effects of MDMA on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting

Introduction

Baggott and colleagues situate their study in the context of longstanding anecdotal and emerging clinical interest in 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy/molly") as a compound with distinctive socioemotional effects. Previous reports and early therapeutic use suggested MDMA reduces defensiveness and enhances interpersonal closeness, and recent clinical trials have tested it as an adjunct for post-traumatic stress disorder. However, the acute socioemotional mechanisms remain poorly characterised: some studies report reduced sensitivity to threat or altered recognition of negative emotions, whereas others find acute increases in self-reported anxiety. The net effect on domains such as social anxiety, self-appraisal, and willingness to disclose autobiographical material is therefore uncertain. This study set out to clarify MDMA's acute socioemotional effects in healthy, MDMA-experienced volunteers. The investigators hypothesised that MDMA might specifically reduce social anxiety (fear of negative evaluation) while increasing sociability and positive self-appraisal, operationalised as state authenticity. To probe disclosure and autobiographical processing, the study incorporated a structured autobiographical speech task to measure comfort, reliving, and narrative content when participants recounted fear, safe, sad, and joyful memories under MDMA versus placebo. The trial was designed as a within-subject, double-blind, placebo-controlled experiment to isolate drug effects on these socioemotional domains.